Press Release: Menarini Silicon Biosystems. : CELLSEARCH CTC count proves its clinical utility in guiding therapeutic strategy supporting patient care in HR+/HER2- metastatic breast cancer

Press Release: Menarini Silicon Biosystems. : Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

Menarini Silicon Biosystems. posted a video "CELLSEARCH Circulating Tumor Cell Test Benefits" on YOUTUBE

Menarini Silicon Biosystems.: Menarini Silicon Biosystems announces new study results on use of CELLSEARCH liquid biopsy for earlier detection of relapse and to help inform decisions on patient management in stage III Melanoma

Menarini Silicon Biosystems.: Menarini Silicon Biosystems announces the launch of its new CELLSEARCH CTC test with the DLL3 biomarker for small cell lung cancer

Menarini Silicon Biosystems. posted a video "MinimuMM-seq: Genome sequencing of CTCs for minimally invasive molecular characterization of MM" on YOUTUBE

Menarini Silicon Biosystems. posted a video "Extending the Liquid Biopsy Concept from Blood to Cerebrospinal" on YOUTUBE